The global molecular diagnostics market is expected to grow at a CAGR of 9.3 percent to reach USD 9333.8 million, during 2016-2020. The infectious diseases segment accounted for the largest share of the global molecular diagnostics market in 2015, followed by blood screening and oncology segments, according to Research and Markets. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market. Increased cost of molecular diagnostics tools, dearth of skilled laboratorians to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market.


Why is The Government So Bad at Health Care?

 

randox

Digital version